Orgenesis Inc. (NASDAQ:ORGS – Get Free Report)’s stock price dropped 5.3% during mid-day trading on Friday . The stock traded as low as $0.90 and last traded at $0.90. Approximately 100 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 6,764 shares. The stock had previously closed at $0.95.
Orgenesis Stock Down 5.3%
The company has a fifty day simple moving average of $0.65 and a 200-day simple moving average of $1.79.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Further Reading
- Five stocks we like better than Orgenesis
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Tesla’s U.S. Market Is At An 8-Year Low… How Bad Could It Get?
- Trading Halts Explained
- Congress: The Biggest Trades Impacting Markets Today
- How to trade using analyst ratings
- 3 Companies Boosting Buybacks While Others Pull Back
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
